Overweight men more likely to die from prostate cancer

Men who are overweight and have high plasma concentrations of C-peptide are more likely to die from prostate cancer, joint US and Canadian research suggests.

The study looked at 2,546 men who were diagnosed with prostate cancer during a 24-year follow-up.

Men who were overweight or obese were significantly more likely to die from their prostate cancer then men of normal weight.

Men with both high C-peptide concentration and high BMI were four times more likely to die from prostate cancer.

The researchers, from the University of Harvard in Boston and McGill University in Montreal, conclude that the findings provide ‘further impetus for men to avoid becoming overweight.’

sanjay.tanday@haymarket.com

The Lancet Oncology Online 2008

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from the shielded patient list in a future wave of...

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide care to shielded patients in 'infection-controlled clinical settings'...

How digital assistants can help patients manage their health and wellbeing

How digital assistants can help patients manage their health and wellbeing

A project in Staffordshire has shown how practices can make use of digital technology...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

The government must do ‘the right thing’ and secure adequate death-in-service benefits...

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...